Amisha V Barochia

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc The Surviving Sepsis Campaign's Revised Sepsis Bundles
    Amisha V Barochia
    National Heart, Lung and Blood Institute, National Institutes of Health, Building 10, Room 2C145, Bethesda, MD, 20892, USA
    Curr Infect Dis Rep 15:385-93. 2013
  2. pmc Bundled care for septic shock: an analysis of clinical trials
    Amisha V Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 38:668-78. 2010
  3. pmc Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
    Amisha Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Building 10, Room 2C145, Bethesda, MD 20892, USA
    Expert Opin Drug Metab Toxicol 7:479-94. 2011
  4. pmc Raxibacumab augments hemodynamic support and improves outcomes during shock with B. anthracis edema toxin alone or together with lethal toxin in canines
    Kenneth E Remy
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bldg 10, Rm 2C145, Bethesda, MD, 20892, USA
    Intensive Care Med Exp 3:9. 2015
  5. pmc Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines
    Amisha V Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
    J Infect Dis 205:818-29. 2012

Collaborators

Detail Information

Publications5

  1. pmc The Surviving Sepsis Campaign's Revised Sepsis Bundles
    Amisha V Barochia
    National Heart, Lung and Blood Institute, National Institutes of Health, Building 10, Room 2C145, Bethesda, MD, 20892, USA
    Curr Infect Dis Rep 15:385-93. 2013
    ..Examination of the revised bundles in the context of issues and questions arising with the original ones suggest that while compliance with new 3-h bundle will be high, compliance with the 6-h bundle will continue to be low. ..
  2. pmc Bundled care for septic shock: an analysis of clinical trials
    Amisha V Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
    Crit Care Med 38:668-78. 2010
    ..Valid bundles require effective components with additive benefits. Proponents encourage evaluation of bundles, both as a whole and based on the performance of each component...
  3. pmc Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
    Amisha Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Building 10, Room 2C145, Bethesda, MD 20892, USA
    Expert Opin Drug Metab Toxicol 7:479-94. 2011
    ..Eritoran tetrasodium (E5564) is a promising candidate therapy for sepsis belonging to a new class of such drugs which inhibit LPS-induced inflammation by blocking toll-like receptor 4...
  4. pmc Raxibacumab augments hemodynamic support and improves outcomes during shock with B. anthracis edema toxin alone or together with lethal toxin in canines
    Kenneth E Remy
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bldg 10, Rm 2C145, Bethesda, MD, 20892, USA
    Intensive Care Med Exp 3:9. 2015
    ..Here we study raxibacumab further. Using this model, we have now studied raxibacumab with 24 h edema toxin challenges (Study 1), and lethal and edema toxin challenges together (Study 2)...
  5. pmc Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines
    Amisha V Barochia
    Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA
    J Infect Dis 205:818-29. 2012
    ..We investigated whether protective antigen-directed monoclonal antibody (PA-mAb) treatment further augments titrated hemodynamic support...